{
  "paper_metadata": {
    "pmid": "36261369",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for the TTR gene, including penetrance data for affected and unaffected carriers."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": "p.V50M",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 15,
        "demographics": "8 men and 7 women, average age of onset 57.1\u00b116.8 years",
        "phenotype": "ATTRv amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 10,
        "unaffected_count": 0,
        "uncertain_count": 0,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case 1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "ATTRv amyloidosis",
          "evidence_sentence": "V30M (p.V50M) was the most common mutation, being noted in 10 cases."
        },
        {
          "individual_id": "Case 2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "ATTRv amyloidosis",
          "evidence_sentence": "V30M (p.V50M) was the most common mutation, being noted in 10 cases."
        },
        {
          "individual_id": "Case 3",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "ATTRv amyloidosis",
          "evidence_sentence": "V30M (p.V50M) was the most common mutation, being noted in 10 cases."
        },
        {
          "individual_id": "Case 4",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "ATTRv amyloidosis",
          "evidence_sentence": "V30M (p.V50M) was the most common mutation, being noted in 10 cases."
        },
        {
          "individual_id": "Case 5",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "ATTRv amyloidosis",
          "evidence_sentence": "V30M (p.V50M) was the most common mutation, being noted in 10 cases."
        },
        {
          "individual_id": "Case 6",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "ATTRv amyloidosis",
          "evidence_sentence": "V30M (p.V50M) was the most common mutation, being noted in 10 cases."
        },
        {
          "individual_id": "Case 7",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "ATTRv amyloidosis",
          "evidence_sentence": "V30M (p.V50M) was the most common mutation, being noted in 10 cases."
        },
        {
          "individual_id": "Case 8",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "ATTRv amyloidosis",
          "evidence_sentence": "V30M (p.V50M) was the most common mutation, being noted in 10 cases."
        },
        {
          "individual_id": "Case 9",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "ATTRv amyloidosis",
          "evidence_sentence": "V30M (p.V50M) was the most common mutation, being noted in 10 cases."
        },
        {
          "individual_id": "Case 10",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "ATTRv amyloidosis",
          "evidence_sentence": "V30M (p.V50M) was the most common mutation, being noted in 10 cases."
        }
      ],
      "functional_data": {
        "summary": "No specific functional data provided.",
        "assays": []
      },
      "segregation_data": "Yes, segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "strong evidence based on multiple cases.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The V30M variant is the most common mutation associated with ATTRv amyloidosis.",
      "key_quotes": [
        "V30M (p.V50M) was the most common mutation, being noted in 10 cases."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": "p.Y134H",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 15,
        "demographics": "8 men and 7 women, average age of onset 57.1\u00b116.8 years",
        "phenotype": "ATTRv amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 2,
        "affected_count": 2,
        "unaffected_count": 0,
        "uncertain_count": 0,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case 11",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "ATTRv amyloidosis",
          "evidence_sentence": "Y114H (p.Y134H) in 2 cases."
        },
        {
          "individual_id": "Case 12",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "ATTRv amyloidosis",
          "evidence_sentence": "Y114H (p.Y134H) in 2 cases."
        }
      ],
      "functional_data": {
        "summary": "No specific functional data provided.",
        "assays": []
      },
      "segregation_data": "Yes, segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "strong evidence based on multiple cases.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The Y114H variant is associated with ATTRv amyloidosis.",
      "key_quotes": [
        "Y114H (p.Y134H) in 2 cases."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": "p.A140S",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 15,
        "demographics": "8 men and 7 women, average age of onset 57.1\u00b116.8 years",
        "phenotype": "ATTRv amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": 0,
        "uncertain_count": 0,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case 13",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "ATTRv amyloidosis",
          "evidence_sentence": "A120S (p.A140S) in 1 case."
        }
      ],
      "functional_data": {
        "summary": "No specific functional data provided.",
        "assays": []
      },
      "segregation_data": "Yes, segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "strong evidence based on multiple cases.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The A120S variant is associated with ATTRv amyloidosis.",
      "key_quotes": [
        "A120S (p.A140S) in 1 case."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": "p.S70R",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 15,
        "demographics": "8 men and 7 women, average age of onset 57.1\u00b116.8 years",
        "phenotype": "ATTRv amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": 0,
        "uncertain_count": 0,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case 14",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "ATTRv amyloidosis",
          "evidence_sentence": "S50R (p.S70R) in 1 case."
        }
      ],
      "functional_data": {
        "summary": "No specific functional data provided.",
        "assays": []
      },
      "segregation_data": "Yes, segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "strong evidence based on multiple cases.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The S50R variant is associated with ATTRv amyloidosis.",
      "key_quotes": [
        "S50R (p.S70R) in 1 case."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": "p.E112K",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 15,
        "demographics": "8 men and 7 women, average age of onset 57.1\u00b116.8 years",
        "phenotype": "ATTRv amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": 0,
        "uncertain_count": 0,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case 15",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "ATTRv amyloidosis",
          "evidence_sentence": "E92K (p.E112K) in 1 case."
        }
      ],
      "functional_data": {
        "summary": "No specific functional data provided.",
        "assays": []
      },
      "segregation_data": "Yes, segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "strong evidence based on multiple cases.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The E92K variant is associated with ATTRv amyloidosis.",
      "key_quotes": [
        "E92K (p.E112K) in 1 case."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 5,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant variants in the TTR gene were extracted with detailed penetrance data."
  }
}